GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT UBC Medical Indonesia Tbk (ISX:LABS) » Definitions » Notes Receivable

PT UBC Medical Indonesia Tbk (ISX:LABS) Notes Receivable : Rp0.00 Mil (As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is PT UBC Medical Indonesia Tbk Notes Receivable?

PT UBC Medical Indonesia Tbk's Notes Receivable for the quarter that ended in . 20 was Rp0.00 Mil.


PT UBC Medical Indonesia Tbk Notes Receivable Historical Data

The historical data trend for PT UBC Medical Indonesia Tbk's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT UBC Medical Indonesia Tbk Notes Receivable Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
Notes Receivable

PT UBC Medical Indonesia Tbk Semi-Annual Data
Notes Receivable

PT UBC Medical Indonesia Tbk Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


PT UBC Medical Indonesia Tbk Notes Receivable Related Terms

Thank you for viewing the detailed overview of PT UBC Medical Indonesia Tbk's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


PT UBC Medical Indonesia Tbk Business Description

Traded in Other Exchanges
N/A
Address
Jalan Rawagelam V, Pulogadung Industrial Area, Block L, No. Kav 11-13, East Jakarta, Jatinegara Subdistrict, Cakung District,, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distributor of medical devices. Its product include NeumoDx, Airdoc Retina AI, QIAstat-Dx, PCR, etc.

PT UBC Medical Indonesia Tbk Headlines